KITE-753

· Kite Pharma, a Gilead Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KITE-753, covering 2026-04-22 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma [Phase 1, Phase 2]